Anlysis on features of dead cases with human Streptococcus suis infections.
- Author:
Xiao-ping ZHU
1
;
Rong-qiang ZU
;
Zhi-hai CHEN
;
Xue-cheng LIU
;
Lun-guang LIU
;
Wen-jun ZHONG
;
Shi-wen WANG
;
Ni-juan XIANG
;
Heng YUAN
;
Ling MENG
;
Yang-bing OU
;
Yong-jun GAO
;
Qiang LV
;
Yan HUANG
;
Xiang-dong AN
;
Ting HUANG
;
Xing-yu ZHOU
;
Liao FENG
;
Qi-di PANG
;
Wei-zhong YANG
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; China; Disease Progression; Female; Humans; Male; Middle Aged; Streptococcal Infections; blood; microbiology; mortality; pathology; Streptococcus suis; physiology; Young Adult
- From: Chinese Journal of Epidemiology 2005;26(9):633-635
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo describe the clinical and epidemiological features of dead cases with human Streptococcus suis infections, and to find the target population for preventing death and the related indicators.
METHODSEpidemiological investigation on human Streptococcus suis infections was implemented used unified questionnaires. Analysis on dead cases and survival cases (as contrast) was done.
RESULTSThe population with highest fatality rate was in 40-49 age group. 97.37% of dead cases had toxic shock syndrome. The mean interval from onset to admission was 0.76 days, and the mean course was 2.11 days. The progression among dead cases was faster than that among survival cases. Chief clinical manifestations of dead cases that are more frequent than survival cases are purpura (73.68%), diarrhea (50.0%), dyspnea (21.05%), conjunctival congestion (34.21%), etc. Renal impairment and liver involvement in dead cases were more significant than that in survival cases. No significant difference between mean incubation period, exposure rates of main risk factors in dead cases and in survival cases was found.
CONCLUSIONPreventing toxic shock syndrome might reduce the fatality rate. The target population for preventing death is aged > or = 40. Liver function and renal function testing might be indicators for monitoring the progression of human Streptococcus suis infections.